International Urogynecology Journal

, Volume 30, Issue 4, pp 545–555 | Cite as

Anatomical outcomes 1 year after pelvic organ prolapse surgery in patients with and without a uterus at a high risk of recurrence: a randomised controlled trial comparing laparoscopic sacrocolpopexy/cervicopexy and anterior vaginal mesh

  • Eduardo Bataller
  • Cristina RosEmail author
  • Sonia Anglès
  • Miriam Gallego
  • Montserrat Espuña-Pons
  • Francisco Carmona
Original Article


Introduction and hypothesis

Few studies have compared the different approaches of mesh surgery in patients with severe pelvic organ prolapse (POP). In addition to laparoscopic sacrocolpopexy/cervicopexy (LSC-Cx), anterior vaginal mesh (AVM) may be an effective approach for correcting anterior vaginal wall associated with apical POP in women with advanced POP.


A randomised controlled trial (RCT; January 2011 to March 2016) including 120 patients (60/group) with advanced symptomatic POP, with a predominant anterior vaginal wall descent stage III or greater in combination with a stage II or III apical defect (uterus or vaginal vault). Patients underwent four visits: baseline, 3, 6 and12 months after surgery. The main outcome was anatomical success defined as anterior and posterior vaginal wall not descending beyond the hymen and vaginal apex descent no more than one third into the vagina. Secondary variables: PFDI, ICIQ-UI-SF, intraoperative variables, postoperative morbidity and complications.


Anatomical success was achieved with LSC-Cx in 79% and with AVM in 76% (NS). No statistically significant differences were found among POP-Q anterior vaginal wall points between groups, whereas better results were obtained with LSC-Cx in posterior vaginal wall points and total vaginal length. Intraoperative outcomes were similar in the two groups, except for operating time (78.05 min LSC-Cx vs 44.28 min AVM). There were no statistically significant differences related to de novo stress urinary incontinence and dyspareunia. Worse results were found in the CRADI-8 in the LSC-Cx group, owing to constipation. Late postoperative complications and reinterventions were similar in the two groups.


No differences were found in the anatomical correction of anterior and apical POP. The LSC-Cx group presented better correction of posterior vaginal wall defects and a longer total vaginal length.


Pelvic organ prolapse Prolapse recurrence Mesh surgery Laparoscopic sacral colpopexy/cervicopexy Anterior vaginal mesh 



We would like to thank Dr Lluís Aragonès for his contribution to the statistical analyses.


The Elevate® Anterior and Apical kits were donated by AMS as a grant for the study without any other support or supervision.

Compliance with ethical standards

Conflicts of interest

Dr Bataller was a consultant for AMS (Astora, women’s health). The remaining authors claim no conflicts of interest.


  1. 1.
    Løwenstein E, Ottesen B, Gimbel H. Incidence and lifetime risk of pelvic organ prolapse surgery in Denmark from 1977 to 2009. Int Urogynecol J. 2015;26(1):49–55. Scholar
  2. 2.
    Khan AA, Eilber KS, Clemens JQ, Wu N, Pashos CL, Anger JT. Trends in management of pelvic organ prolapse among female Medicare beneficiaries. Am J Obstet Gynecol. 2015;212(4):463.e1–8. Scholar
  3. 3.
    Glazener CM, Breeman S, Elders A, et al. Mesh, graft, or standard repair for women having primary transvaginal anterior or posterior compartment prolapse surgery: two parallel-group, multicentre, randomised, controlled trials (PROSPECT). Lancet. 2016;389:(10067):381–92
  4. 4.
    Oversand SH, Staff AC, Spydslaug AE, Svenningsen R, Borstad E. Long-term follow-up after native tissue repair for pelvic organ prolapse. Int Urogynecol J. 2014;25(1):81–9. Scholar
  5. 5.
    Dällenbach P, Jungo Nancoz C, Eperon I, Dubuisson J-B, Boulvain M. Incidence and risk factors for reoperation of surgically treated pelvic organ prolapse. Int Urogynecol J. 2012;23(1):35–41. Scholar
  6. 6.
    Gotthart PT, Aigmueller T, Lang PFJ, Ralph G, Bjelic-Radisic V, Tamussino K. Reoperation for pelvic organ prolapse within 10 years of primary surgery for prolapse. Int Urogynecol J. 2012;23(9):1221–4. Scholar
  7. 7.
    Manodoro S, Frigerio M, Cola A, Spelzini F, Milani R. Risk factors for recurrence after hysterectomy plus native-tissue repair as primary treatment for genital prolapse. Int Urogynecol J. 2018;29(1):145–51. Scholar
  8. 8.
    Friedman T, Eslick GD, Dietz HP. Risk factors for prolapse recurrence: systematic review and meta-analysis. Int Urogynecol J. 2018;29(1):13–21. Scholar
  9. 9.
    Vergeldt TFM, Weemhoff M, IntHout J, Kluivers KB. Risk factors for pelvic organ prolapse and its recurrence: a systematic review. Int Urogynecol J. 2015;26(11):1559–73. Scholar
  10. 10.
    Maher C, Feiner B, Baessler K, Schmid C. Surgical management of pelvic organ prolapse in women. In: Maher C, editor. Cochrane database of systematic reviews. Chichester: Wiley; 2013. p. CD004014. Scholar
  11. 11.
    Maher CF, Qatawneh AM, Dwyer PL, Carey MP, Cornish A, Schluter PJ. Abdominal sacral colpopexy or vaginal sacrospinous colpopexy for vaginal vault prolapse: a prospective randomized study. Am J Obstet Gynecol. 2004;190(1):20–6. Scholar
  12. 12.
    Freeman RM, Pantazis K, Thomson A, et al. A randomised controlled trial of abdominal versus laparoscopic sacrocolpopexy for the treatment of post-hysterectomy vaginal vault prolapse: LAS study. Int Urogynecol J. 2013;24(3):377–84. Scholar
  13. 13.
    Vandendriessche D, Giraudet G, Lucot J-P, Behal H, Cosson M. Impact of laparoscopic sacrocolpopexy learning curve on operative time, perioperative complications and short term results. Eur J Obstet Gynecol Reprod Biol. 2015;191:84–9. Scholar
  14. 14.
    Jia X, Glazener C, Mowatt G, et al. Systematic review of the efficacy and safety of using mesh in surgery for uterine or vaginal vault prolapse. Int Urogynecol J. 2010;21(11):1413–31. Scholar
  15. 15.
    Maher CF, Feiner B, DeCuyper EM, Nichlos CJ, Hickey KV, O’Rourke P. Laparoscopic sacral colpopexy versus total vaginal mesh for vaginal vault prolapse: a randomized trial. Am J Obstet Gynecol. 2011;204(4):360.e1–7. Scholar
  16. 16.
    Gracia M, Perelló M, Bataller E, et al. Comparison between laparoscopic sacral hysteropexy and subtotal hysterectomy plus cervicopexy in pelvic organ prolapse: a pilot study. Neurourol Urodyn. 2015;34(7):654–8. Scholar
  17. 17.
    Stanford EJ, Moore RD, J-PWR R, et al. Elevate and uterine preservation. Female Pelvic Med Reconstr Surg. 2015;21(4):205–10. Scholar
  18. 18.
    Barber MD, Brubaker L, Burgio KL, et al. Comparison of 2 transvaginal surgical approaches and perioperative behavioral therapy for apical vaginal prolapse. JAMA. 2014;311(10):1023. Scholar
  19. 19.
    Haylen BT, Maher CF, Barber MD, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic organ prolapse (POP). Int Urogynecol J. 2016;27(2):165–94. Scholar
  20. 20.
    Haylen BT, Freeman RM, Swift SE, et al. An international urogynecological association (IUGA)/international continence society (ICS) joint terminology and classification of the complications related directly to the insertion of prostheses (meshes, implants, tapes) and grafts in female pelvic floor surgery. Neurourol Urodyn. 2011;30(1):2–12.
  21. 21.
    Bump RC, Mattiasson A, Bø K, et al. The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol. 1996;175(1):10–7. Scholar
  22. 22.
    Maher C, Feiner B, Baessler K, Christmann-Schmid C, Haya N, Marjoribanks J. Transvaginal mesh or grafts compared with native tissue repair for vaginal prolapse. In: Maher C, editor. Cochrane database of systematic reviews, vol 2. Chichester: Wiley; 2016. p. CD012079. Scholar
  23. 23.
    Sanses TV, Shahryarinejad A, Molden S, et al. Anatomic outcomes of vaginal mesh procedure (Prolift) compared with uterosacral ligament suspension and abdominal sacrocolpopexy for pelvic organ prolapse: a Fellows’ Pelvic Research Network study. Am J Obstet Gynecol 2009;201(5):519.e1–519.e8. Scholar
  24. 24.
    Lucot J-P, Fritel X, Debodinance P, et al. Étude randomisée comparant la promontofixation cœlioscopique à la chirurgie prothétique par voie vaginale pour le traitement des cystocèles : PROSPERE (PROSthetic PElvic organ prolapse REpair). J Gynécol Obstet Biol Reprod. 2013;42(4):334–41. Scholar
  25. 25.
    Fauconnier A, Cosson M, Debodinance P, Bader G, Youssef Azer Akladios C, Salet-Lizee D, et al. Anatomical and functional outcomes of vaginal mesh surgery versus laparoscopic sacrocolpohysteropexy for cystocele repair: 12-month results of the PROSPERE (PROSthetic PElvic floor REpair) randomised controlled trial. Neurourol Urodynam Abstr. 2016;35(S1):S471.Google Scholar
  26. 26.
    Gutman RE, Rardin CR, Sokol ER, et al. Vaginal and laparoscopic mesh hysteropexy for uterovaginal prolapse: a parallel cohort study. Am J Obstet Gynecol. 2017;216(1):38.e1–11.
  27. 27.
    To V, Hengrasmee P, Lam A, Luscombe G, Lawless A, Lam J. Evidence to justify retention of transvaginal mesh: comparison between laparoscopic sacral colpopexy and transvaginal elevate™ mesh. Int Urogynecol J. 2017;28(12):1825–32. Scholar
  28. 28.
    Fatton B, Amblard J, Debodinance P, Cosson M, Jacquetin B. Transvaginal repair of genital prolapse: preliminary results of a new tension-free vaginal mesh (Prolift™ technique)—a case series multicentric study. Int Urogynecol J. 2007;18(7):743–52. Scholar
  29. 29.
    De Tayrac R, Gervaise A, Chauveaud A, Fernandez H. Tension-free polypropylene mesh for vaginal repair of anterior vaginal wall prolapse. J Reprod Med. 2005;50(2):75–80.
  30. 30.
    Gutman R, Maher C. Uterine-preserving POP surgery. Int Urogynecol J. 2013;24(11):1803–13. Scholar
  31. 31.
    Roovers J-P, van der Vaart CH, van der Bom JG, van Leeuwen JHS, Scholten PC, Heintz APM. A randomised controlled trial comparing abdominal and vaginal prolapse surgery: effects on urogenital function. BJOG. 2004;111(1):50–6. Scholar

Copyright information

© The International Urogynecological Association 2018

Authors and Affiliations

  • Eduardo Bataller
    • 1
  • Cristina Ros
    • 1
    • 2
    Email author
  • Sonia Anglès
    • 1
  • Miriam Gallego
    • 1
  • Montserrat Espuña-Pons
    • 1
  • Francisco Carmona
    • 1
  1. 1.Institut Clínic de Ginecologia, Obstetrícia i Neonatologia (ICGON), Hospital Clínic i Provincial de BarcelonaUniversitat de BarcelonaBarcelonaSpain
  2. 2.Institut Clínic de Ginecologia, Obstetrícia i Neonatologia (ICGON), ICGONHospital Clínic de BarcelonaBarcelonaSpain

Personalised recommendations